There is a worldwide epidemic of obesity, type 2 diabetes and metabolic syndrome, all conditions linked to insulin resistance 1,2 . Although multiple mechanisms contribute to the development of insulin resistance in these disorders, one major mechanism is the activation of cellular stress and inflammatory signaling pathways 3,4 . Understanding exactly how these stress pathways are linked to insulin signaling dynamics is crucial.
There is a worldwide epidemic of obesity, type 2 diabetes and metabolic syndrome, all conditions linked to insulin resistance 1,2 . Although multiple mechanisms contribute to the development of insulin resistance in these disorders, one major mechanism is the activation of cellular stress and inflammatory signaling pathways 3, 4 . Understanding exactly how these stress pathways are linked to insulin signaling dynamics is crucial.
Class Ia PI3Ks are a family of lipid kinases that regulate multiple cellular processes, including cell metabolism and growth, by virtue of their ability to generate the second messenger, phosphatidylinositol-3,4,5-trisphosphate 5 . This enzyme exists as an obligate heterodimer, composed of a regulatory and catalytic subunit, both of which occur in several isoforms. The central role of this enzyme in mediating the metabolic actions of insulin is apparent from studies where expression of dominant-negative constructs or pharmacological inhibition of PI3K completely abolishes insulin stimulation of glucose transport, lipogenesis and glycogen synthesis 6, 7 . Alterations in insulin stimulation of PI3K activity have been observed in mouse models of obesity, as well as in humans with type 2 diabetes [8] [9] [10] .
The ER forms an interconnected, membranous network that is the major site of synthesis and folding of secreted and integral membrane proteins. Protein folding in the ER lumen is facilitated by a number of molecular chaperones, including the glucose-regulated proteins BiP and Grp94, and a variety of folding enzymes such as protein disulfide isomerase (PDI) 11, 12 . Physiological states that increase protein synthesis, or stimuli that disrupt the processes by which proteins obtain their native conformation, create an imbalance between the protein-folding demand and capacity of the ER. This results in the accumulation of unfolded or improperly folded proteins in the ER lumen and a state of ER stress. The cellular response to ER stress, referred to as the UPR, results in activation of three linked signal transduction pathways emanating from three principle ER stress sensors: IRE1α, double-stranded RNA-dependent protein kinase-like kinase (PERK) and ATF6α 13, 14 . The combined actions of these signaling cascades serve to reduce ER stress through attenuation of protein translation to reduce the load on the ER translational machinery and through activation of transcriptional programs that ultimately serve to increase ER protein folding and maturation.
Pathophysiological states including obesity, hyperlipidemia, nutrient deprivation, hypoxia, infection and inflammation have been shown to disrupt ER homeostasis [15] [16] [17] [18] . For example, mice with genetic or diet-induced obesity show a considerable elevation in ER stress, with elevated phosphorylation of PERK and IRE1α and enhanced splicing of XBP-1 (ref. 19) . Several markers of ER stress are also elevated in adipose tissue from obese humans 18, 20 . Conversely, the increase in insulin sensitivity associated with weight loss is associated with a substantial reduction in markers of UPR activation 21 . Furthermore, mice given chemical chaperones that facilitate protein folding or transgenic mice overexpressing the ER chaperone 150-kDa oxygen-regulated protein show improvements in obesity-associated insulin resistance and glucose metabolism 22, 23 . Mechanistically, activation of the UPR in the obese state contributes to the decrease in insulin sensitivity through IRE1α-dependent activation of c-Jun N-terminal kinase (JNK), which leads to phosphorylation of insulin receptor substrate-1 (IRS-1) on inhibitory serine residues [24] [25] [26] .
Additional evidence establishing a mechanistic link between IRE1α and UPR-associated insulin resistance comes from studies of mice haploinsufficient for XBP-1. Normally, in response to ER stress, IRE1α executes site-specific cleavage of XBP-1 messenger RNA to produce a transcript (XBP-1s) that encodes a potent transcriptional activator of UPR target genes 27, 28 . When subjected to a high-fat diet, XBP-1-heterozygous mice gain more weight and become more insulin resistant than control mice 19 . These mice also show an increase in ER stress in adipose tissue, with enhanced PERK and IRE1α phosphorylation and activation of JNK. Likewise, XBP-1-deficient fibroblasts show enhanced PERK phosphorylation, hyperactivation of JNK and increased serine phosphorylation of IRS-1 (ref. 19) . Collectively, these data demonstrate how the ER stress response and alterations in XBP-1 can modulate insulin sensitivity.
Here we show another link between insulin signaling and the UPR. We show that the p85α regulatory subunit of PI3K interacts with XBP-1 in an ER stress-dependent manner and that this interaction is essential in the ER stress response. As a result, cells deficient in p85α or livers with selective inactivation of the gene encoding p85α show a marked reduction in ER stress and accumulation of nuclear XBP-1s protein and its downstream target proteins. This link between the regulatory subunit of PI3K and the cellular response to ER stress provides a new therapeutic target for the treatment of diseases in which the UPR is activated, such as obesity and type 2 diabetes.
RESULTS p85 associates with an XBP-1-containing protein complex
In previous studies, we have shown that deletion of the p85α subunit of PI3K results in decreased activation of JNK and increased insulin sensitivity and that this depends on the N-terminal half of p85α and is independent of its role in PI3K activation [29] [30] [31] . To identify proteins that interact with the N-terminal region of p85α, we performed an interaction screen with a bacterial two-hybrid system and a human liver complementary DNA library (Fig. 1a) . Sequencing of isolated cDNA clones revealed that one p85α interacting partner was the transcription factor XBP-1. The XBP-1-interacting cDNA encoded the NH 2 -terminal portion of the XBP-1 protein, a region shared between the unspliced (XBP-1u) and spliced (XBP-1s) isoforms (Fig. 1a) .
To confirm that the association between p85α and XBP-1 observed in the bacterial two-hybrid screen could also occur in mammalian cells, we performed coimmunoprecipitation experiments with extracts of cells transfected with HA-p85α and Flag-XBP-1s expression plasmids alone or in combination (Fig. 1b) . Although we did not find XBP-1 in HA immunoprecipitates from cells transfected with HA-p85α or Flag-XBP-1s alone, we found abundant Flag-XBP-1s in HA-p85α immunoprecipitates when both proteins were expressed (Fig. 1b) . Notably, there was a marked reduction in the association between XBP-1s and p85α after treatment with tunicamycin, suggesting that this interaction is regulated by ER stress (Fig. 1b) . We obtained similar results when we infected rat hepatoma cells with adenoviruses expressing either GFP or p85α with an N-terminal tandem affinity purification (TAP) tag containing the streptavidin and calmodulin binding domains (Supplementary Fig. 1) 32, 33 . These data demonstrate that p85α and XBP-1 physically associate and that this interaction is modulated by the cellular response to ER stress. p85 promotes stabilization and nuclear accumulation of XBP-1 Degradation of XBP-1 involves both ubiquitin-dependent and ubiquitin-independent mechanisms, resulting in short half-lives of both the XBP-1u and the XBP-1s proteins 34 . To determine whether p85α alters the stability of XBP-1, we transiently transfected HEK293 cells with plasmids encoding XBP-1 or p85α either alone or in combination. Concurrent expression of XBP-1 with p85α led to a substantial increase in the amount of XBP-1u and XBP-1s in the cytoplasm and nucleus, respectively (Fig. 1c) .
In contrast to XBP-1u, XBP-1s is primarily localized to the nucleus. Expression of an N-terminal deletion of XBP-1s leads to its redistribution to both the cytoplasm and the nucleus, suggesting that this region of XBP-1s governs its nuclear localization 34, 35 . Having established that p85α and XBP-1 interact and that the interaction occurs between the N-terminal portion of p85α and the shared N-terminal fragment of XBP-1 capable of directing nuclear localization, we examined whether p85α is able to alter the cellular distribution of XBP-1. To this end, we transiently transfected cells with Flag-XBP-1s in the absence or presence of increasing amounts of HA-p85α and performed immunoblotting on cytoplasmic and nuclear fractions with Flag-specific antibodies. Notably, the dose-dependent increase in HA-p85α resulted in a parallel increase in the nuclear translocation of XBP-1s (Fig. 1d) . Thus, increasing the abundance of p85α leads to the stabilization of XBP-1 and enhances the nucleocytoplasmic shuttling of XBP-1.
Fibroblasts lacking p85 show an altered response to ER stress
Given the central role of XBP-1 as a mediator of the UPR, we sought to determine whether the interaction between p85α and XBP-1 is involved in control of the cellular response to ER stress. We treated immortalized control (Pik3r1 +/+ ) and p85α-deficient (Pik3r1 −/− ) brown preadipocyte cell lines 29 with vehicle or tunicamycin and assessed BiP and XBP-1s protein expression in cytoplasmic or nuclear compartments (Fig. 2a) . As expected, treatment of control preadipocytes with tunicamycin for 4 h resulted in the appearance of BiP, and immunoblots performed on nuclear lysates revealed a timedependent accumulation of XBP-1s (Fig. 2a) . By contrast, when we treated Pik3r1 −/− cells with tunicamycin, BiP induction was reduced by 50%, and there was markedly less nuclear accumulation of XBP-1s, with no detectable nuclear XBP-1s at 3 h and a 40% reduction in nuclear XBP-1s after 4 h when compared to Pik3r +/+ cells treated in parallel (Fig. 2a) . Thus, the absence of p85α alters the cellular response to ER stress with a decrease in nuclear accumulation of XBP-1s and reduced expression of BiP.
To exclude the possibility that the defect observed in Pik3r1 −/− cells is the result of reduced sensitivity to UPR activation, we performed a dose-response analysis with tunicamycin. As expected, Pik3r1 +/+ cells showed a dose-dependent increase in BiP expression after treatment with 0.1-5 µg ml −1 tunicamycin (Fig. 2b) . In Pik3r1 −/− cells treated with tunicamycin, BiP protein expression showed a dose-dependent increase; however, BiP amounts were 50-60% lower at all tunicamycin concentrations (Fig. 2b) . Likewise, there was a dose-dependent 10-to 20-fold increase in BiP and the ER stress-induced transcription factor C/EBP-homologous protein (CHOP) mRNA levels after tunicamycin treatment in control cells, whereas p85α-deficient cells showed a 50-60% reduction in BiP and CHOP mRNA levels at all concentrations (Fig. 2b) . We observed a similar reduction in the UPR targets BiP and CHOP at the mRNA and protein levels when we used thapsigargin to activate the UPR (Supplementary Figs. 2 and 3 and data not shown). These effects were independent of PI3K enzyme activity, as pharmacological inhibition of PI3K with LY294002 had no effect on the induction of BiP expression after tunicamycin or thapsigargin treatment ( Supplementary  Fig. 4 ). In addition, attempts to coimmunoprecipitate p110α and XBP-1 failed to identify an interaction, thereby providing an additional indication that the role of p85α as it relates to XBP-1 function is independent of p110α action.
UPR pathways are altered in p85-deficient fibroblasts
Given the above results, it was clear that p85α deficiency severely impairs the cellular response to ER stress, with reduced expression of BiP and nuclear accumulation of XBP-1s in response to UPR activation. p85α deficiency was also associated with alterations in IRE1α-and ATF6α-dependent signaling pathways. Thus, whereas control cells responded to tunicamycin treatment with a considerable upregulation of IRE1α protein and an enhancement of IRE1α phosphorylation, Pik3r1 −/− cells showed an ~20-40% reduction of IRE1α expression in the basal state and after tunicamycin treatment and an associated reduction in IRE1α phosphorylation (Fig. 2c) . Notably, although we readily observed alteration in IRE1α activation, there were no a b c d Control and Pik3r1 −/− fibroblasts were treated with vehicle or tunicamycin (2 µg ml −1 ) for 5 h. Actin-specific immunoblotting was performed to confirm equal protein loading. (d) Immunoblot analysis on nuclear lysates with XPB-1-, ATF6-and CHOP-specific antibodies. Control and Pik3r1 −/− fibroblasts were treated with tunicamycin (2 µg ml −1 ) over the indicated time course. Laminin A/C-specific immunoblotting was performed to confirm equal loading. Data are presented as the means ± s.e.m., and asterisks indicate statistical significance determined by Student's t test (*P < 0.05, n = 3 experiments). differences in PERK abundance or activation between control and Pik3r1 −/− cells, as assessed by alterations in PERK mobility or phosphorylation ( Fig. 2c and data not shown) . Activation of ATF6α, as assessed by immunoblot analysis of the processed form of ATF6α in nuclear lysates, was also markedly attenuated in Pik3r1 −/− cells at the 3-h and 5-h time points and paralleled the blunted response in accumulation of nuclear XBP-1s and induction of CHOP (Fig. 2d) . Thus, p85α deficiency attenuates the cellular response to ER stress through multiple mechanisms involving alterations in the induction of XBP-1s and activation of IRE1α-and ATF6-dependent pathways.
XBP-1 splicing and UPR gene expression in Pik3r1 −/− cells
To examine whether alterations in the IRE1α pathway lead to a reduction in XBP-1 splicing capacity in Pik3r1 −/− fibroblasts, we performed an XBP-1 splicing assay. As expected, untreated control fibroblasts produced primarily the XBP-1u transcript, with only a small amount of XBP-1 migrating at the expected size of the spliced transcript (Supplementary Fig. 5a ). Treatment of these cells with tunicamycin resulted in a marked decrease in XBP-1u and a concomitant increase in XBP-1s transcript levels (Supplementary Fig. 5a ). In contrast, Pik3r1 −/− cells showed a reduction in XBP-1u transcript levels in the basal state and a relatively modest increase in spliced XBP-1 transcript levels after treatment with tunicamycin (Supplementary Fig. 5a ). Quantitative PCR analysis showed a 2.5-fold increase in total XBP-1 transcript levels after tunicamycin treatment in control cells (Supplementary Fig. 5b , P < 0.05). In p85α-deficient cells, total XBP-1 transcript levels were reduced by 50% in the basal state, and there was a significantly attenuated, tunicamycin-dependent increase when compared to controls. (Supplementary Fig. 5b , P < 0.001). Likewise, in control cells, tunicamycin produced an ~30-fold increase in XBP-1s mRNA levels (100% ± 2.45% versus 3,067% ± 778%, vehicle versus tunicamycin, percentage of Pik3r1 +/+ vehicle), and this response was markedly blunted in p85α-deficient cells (91% ± 29% versus 1,181% ± 193%, vehicle versus tunicamycin, percentage of Pik3r1 +/+ vehicle) (Supplementary Fig. 5b) . Thus, p85α deficiency decreases IRE1α-dependent XBP-1 splicing in response to ER stress.
We next sought to establish the extent to which the defects in IRE1α protein and phosphorylation and decreased transcription and splicing of XBP-1 mRNA in Pik3r1 −/− cells alters the induction of UPR target genes. Analysis of control fibroblasts treated with tunicamycin for 5 h revealed 50-60% increases in the expression of multiple mRNAs for UPR targets, including BiP, Grp94, CHOP, protein kinase inhibitor of 58 kDa (p58 IPK ), IRE1α, ATF4 and Tribbles homolog-3 (TRB3) (Fig. 3a) . In contrast, the transcriptional profile in Pik3r −/− cells could be classified into two distinct categories. The first included mRNAs such as BiP, CHOP and ATF4 that were upregulated by tunicamycin but to a much lower level than that achieved in control cells (Fig. 3a) . The second included mRNAs whose expression was significantly elevated in control cells after induction of ER stress, including Grp94 (P < 0.05), p58 IPK (P < 0.05), IRE1α (P < 0.05) and TRB3 (P < 0.01), but showed a nonsignificant increase in Pik3r1 −/− cells after treatment with tunicamycin (Fig. 3a) .
Lastly, to evaluate the outcome of blunted UPR activation in p85α-deficient cells, we measured apoptosis in control and Pik3r1 −/− preadipocytes after treatment with tunicamycin and thapsigargin ( Fig. 3b  and Supplementary Fig. 6 ). As expected, treatment of Pik3r1 +/+ and Pik3r1 −/− cells for 24 h with tunicamycin or thapsigargin increased the rates of apoptosis when compared to cells grown in normal medium ( Fig. 3b and Supplementary Fig. 6 ). Of note, a higher proportion of p85α-deficient cells became apoptotic after treatment with tunicamycin (13.1% ± 3.7% versus 21.6% ± 3.5%, Pik3r1 +/+ versus Pik3r1 −/− ) and thapsigargin (5.8% ± 0.9% versus 18.2% ± 3.0%). Thus, by all criteria tested, p85α-deficient cells show a failure to normally activate the UPR and resolve ER stress. This dysfunction leads to deleterious outcomes, including a propensity to enter apoptotic programs.
Lowering p85 expression in Huh7 cells alters the UPR
We observed similar effects of p85α deficiency in human Huh7 hepatoma cells after lentivirus-mediated short hairpin RNA knockdown of p85α mRNA. With this approach, we achieved a 78% decrease in p85α mRNA levels when compared to control cells expressing shRNA specific for GFP (shGFP) (Fig. 3c) , and we confirmed this by immunoblot analysis with p85α-specific antibodies (Fig. 3d) . Control cells exposed to tunicamycin also showed a marked increase in XBP-1s protein abundance, whereas we did not detect any XBP-1 in cells after p85α knockdown (Fig. 3d) . In addition, there was an attenuated increase in PDI in p85α-deficient cells (Fig. 3d) . Similarly, treatment and Grp94 mRNA expression in shGFP and shp85α cell lines before or after treatment with tunicamycin (2 µg ml −1 ) for 5 h. Data are presented as the means ± s.e.m., and asterisks indicate statistical significance determined by Student's t test (*P < 0.05; **P < 0.001; ***P < 0.005; n.s., not significant) (n = 3 experiments). Significance is relative to basal conditions for each cell line unless otherwise indicated with bars.
of shGFP cells with tunicamycin led to a robust transition from the XBP-1u to XBP-1s transcript, whereas splicing of the XBP-1 transcript after tunicamycin treatment was diminished in cells expressing shRNA to p85α (shp85α), as reflected by lower levels of XBP-1s transcript and an associated increase in XBP-1u mRNA when compared with controls (Supplementary Fig. 5c ). As a result, the tunicamycin-dependent induction of the UPR target proteins endoplasmic reticulum DnaJ homolog-4 (ERdj4) and BiP was attenuated in shp85α cells when compared to controls (Fig. 3e) . Thus, p85α deficiency alters the cellular response to ER stress independently of cell type or stimulus, indicating a major role of the interaction between p85α and XBP-1 in ER stress induction and the UPR.
A blunted UPR is observed in livers of L-Pik3r1 −/− mice
To determine whether the effects observed in vitro would be recapitulated in vivo, we used mice in which the Pik3r1 gene is selectively inactivated in liver by the Cre-loxP system (L-Pik3r1 -/-mice). At 2 months of age, we gave male mice vehicle or tunicamycin (2.5 µg per g body weight) and, after 72 h, collected livers for analysis.
Immunoblots confirmed the absence of p85α in lysates from vehicleand tunicamycin-treated L-Pik3r1 −/− mice (Fig. 4a) . As anticipated, PERK and IRE1α phosphorylation was low in vehicle-treated L-Pik3r1 lox/lox mice, but it increased substantially after tunicamycin administration (Fig. 4a) . In contrast, livers from L-Pik3r1 −/− mice had undetectable basal IRE1α phosphorylation and a markedly blunted, tunicamycin-dependent increase in IRE1α phosphorylation, with no considerable alteration in activation of the PERK pathway (Fig. 4a) . There was also a marked, tunicamycin-dependent increase in total IRE1α and BiP protein abundance in control mice, and these responses were severely blunted in L-Pik3r1 −/− mice (Fig. 4a) . We observed a similar blunting of the UPR and reduced activation of the ATF6α pathway 18 h after administration of tunicamycin (Supplementary Fig. 7) . Likewise, as early as 4 h after tunicamycin administration, the increase in BiP protein was significantly blunted in p85α-deficient livers when compared to controls (347.5% versus 131.8%, L-Pik3r1 +/+ versus L-Pik3r1 −/− , P < 0.05), despite normal activation of the PERK pathway (Fig. 4b) . Thus, activation of the IRE1α and ATF6α pathways and the ER stress response pathways are impaired in the livers of p85α-deficient mice. Unlike the defect observed in Pik3r1 −/− cells, this impairment occurred independently of alterations in XBP-1 splicing (Fig. 4c) .
The attenuated response to ER stress in livers from L-Pik3r1 −/− mice was accompanied by altered expression of UPR-dependent target genes. In liver of control mice, BiP mRNA expression increased fivefold (100% ± 8.2% versus 579% ± 131%) in response to tunicamycin treatment, whereas in L-Pik3r1 −/− mice the increase in BiP was reduced by ~50% and failed to reach statistical significance (Fig. 5a) . Likewise, in control mice, tunicamycin elicited a threefold increase in p58 IPK mRNA (100% ± 10.1% versus 288% ± 39.6%, P < 0.001), and this response was blunted in the livers of L-Pik3r1 −/− mice (88.2% ± 5.2% versus 187% ± 39%, P < 0.05).
We did observe some differences between the in vivo and in vitro studies. Thus, in vivo PERK and growth arrest-and DNA damage-inducible-34 (Gadd34) mRNA levels were elevated to a similar extent in livers from L-Pik3r1 lox/lox and L-Pik3r1 −/− mice after tunicamycin treatment. In addition, tunicamycin administration in vivo caused a comparable increase in XBP-1 splicing in L-Pik3r1 lox/lox and L-Pik3r1 −/− mice (Fig. 5b,c) . In contrast, the robust 17-fold increase (100 ± 39.4 versus 1,749 ± 74.4) in the nuclear XBP-1s protein in controls after tunicamycin treatment was blunted by >50% (160% ± 25.9% versus 830% ± 117%) in livers of L-Pik3r1 −/− mice (Fig. 5d) . Thus, deletion of p85α does not affect all UPR-dependent pathways equally, and the extent of pathway involvement can be affected by other aspects of cellular context.
L-Pik3r1 −/− livers fail to adequately resolve ER stress
To evaluate the outcomes associated with impairment in the UPR of L-Pik3r1 −/− mice, we assessed apoptosis in the liver after tunicamycin administration. To our surprise, despite the increase in CHOP induction in the livers of L-Pik3r1 −/− mice relative to L-Pik3r1 lox/lox mice after 18 h (Fig. 6a) (11.7 ± 7. 3 versus 54 ± 17.7) or 36 h (data not shown) (1.5 ± 0.4 versus 16.8 ± 6.8) of treatment, we could not detect any increases in apoptosis by TUNEL or by immunoblot analysis of cleaved caspase-3 (data not shown). Histological analysis, however, revealed marked changes in livers from tunicamycin-treated L-Pik3r1 −/− mice, including edema and dilation of the sinusoids and bile ducts, when compared to vehicle-treated controls (Supplementary Fig. 8 ). In contrast, the livers of Pik3r1 lox/lox mice treated with vehicle or tunicamycin appeared normal (Supplementary Fig. 8) .
One pathological outcome of unresolved stress in the liver is an inflammatory response. Immunohistochemistry of liver sections with antibodies to the macrophage marker F4/80 revealed only sporadic staining in vehicle-treated control and L-Pik3r1 −/− livers (Fig. 6b) . After tunicamycin treatment, there were more F4/80 + cells in the livers of Pik3r1 lox/lox mice, whereas there was a marked increase in the number of F4/80 + cells in L-Pik3r1 −/− livers when compared to controls (Fig. 6b) . Analysis of mRNA expression revealed a parallel change in the macrophage marker CD68 and the inflammatory cytokine tumor necrosis factor-α (TNF-α) (Fig. 6c) . Consistent with increased macrophage recruitment, livers from L-Pik3r1 −/− mice also showed greater activation of the nuclear factor-κB pathway compared to controls, as revealed by a reduction in inhibitor of κB expression after tunicamycin administration (-36.6% versus -18.6%, L-Pik3r1 lox/lox versus L-Pik3r1 −/− relative to saline control) (Supplementary Fig. 8 ). These data suggest that p85α deficiency alters the fundamental ability of the liver to resolve ER stress, leading to pathological states of inflammation.
DISCUSSION
The ER stress response has been strongly implicated in the pathophysiology of diabetes, affecting both insulin sensitivity in liver and fat, and the survival of pancreatic beta cells [36] [37] [38] [39] . Adipose tissues from obese, insulin-resistant mice and humans show a persistent low level of inflammation and activation of ER stress pathways, including induction of the UPR 4, 19, 40 . Identifying points of regulatory convergence that can serve as therapeutic targets to improve insulin sensitivity and relieve ER stress associated with obesity is therefore of great necessity.
Previous studies have demonstrated that PI3K is central to the actions of insulin, as well as other hormones and growth factors 6, 7, 41, 42 . Although induction of ER stress has been shown to reduce insulin-stimulated AKT activation and decrease insulin receptor substrate tyrosine phosphorylation 19 , to date there has been no evidence establishing a direct link between the PI3K pathway and ER stress. In this study, we show a new and unexpected role for the p85α regulatory subunit of PI3K as a crucial modulator of the cellular response to ER stress. This occurs via a mechanism involving p85α-dependent regulation of XBP-1s protein expression, XBP-1s nuclear translocation and ATF6α activation. Because the level of p85α can change in some insulin-resistant states, including obesity, pregnancy 43 and states of growth hormone excess 44, 45 , as well as in some cancers 46, 47 , a link between p85α and the cellular response to ER stress has major implications for understanding of a broad range of UPR-associated diseases, including diabetes, cancer and a variety of other disorders.
Our data demonstrate that p85α and XBP-1 physically associate and that this interaction modulates the cellular response to ER stress. Our identification of XBP-1 as a p85α-interacting partner with the bacterial two-hybrid system indicates that the association is direct. Our coprecipitation experiments reveal that p85α and XBP-1s interact in a protein complex that dissociates after treatment with tunicamycin, indicating that this interaction is dynamically regulated by ER stress. Although the precise mechanisms regulating a b c this interaction remain to be elucidated, the physical interaction clearly involves the N-terminal portion of p85α and a domain shared by both XBP-1 isoforms. The N-terminal region of p85α has also been shown to bind several other protein partners, including c-Cbl (a substrate for the insulin receptor kinase), the small GTPase Rac1 and cell division control protein-42, indicating a number of key roles for the p85α regulatory subunit of PI3K in addition to its role as a partner in the p85-p110 heterodimer 48, 49 .
The interaction between p85 and XBP-1s alters the UPR through several mechanisms. Enforced expression of p85α leads to an increase in XBP-1 protein stability and enhanced nuclear accumulation of XBP-1s. Conversely, deficiency or reduction in p85α expression in cultured cells results in a considerably attenuated UPR. This includes a reduction in IRE1α and ATF6 pathway activation and a concomitant reduction in the expression of UPR targets at the mRNA and protein levels. This is accompanied by a marked reduction in nuclear accumulation of XBP-1s after treatment with tunicamycin. Collectively, these changes are associated with a relative failure of p85α-deficient cells to resolve ER stress, as indicated by a substantial increase in apoptosis after induction of ER stress.
We also found alterations in the UPR in mice with a liverspecific deletion of p85α, including a reduced induction of the UPR targets BiP, Grp94 and CHOP at both the mRNA and protein levels. L-Pik3r1 −/− mice also show a reduction in IRE1α expression and activation and a marked reduction in accumulation of XBP-1s in the nucleus after induction of ER stress. In contrast to isolated cells, we did not observe any alteration in XBP-1 splicing in the livers of L-Pik3r1 −/− mice after acute stimulation with tunicamycin. These data are in accordance with the study by Park et al. 50 in this issue, which indicates that enforced expression of either p85α or p85β leads to an increase in XBP-1s nuclear localization, whereas knockdown of both regulatory subunits leads to a reduction in the nuclear accumulation of XBP-1s, providing further evidence for a critical role of PI3K regulatory subunits in modulating the UPR. Thus, lowering expression of p85α can modify the UPR by several mechanisms, including a reduction in XBP-1 protein abundance due to altered protein stabilization, decreased nuclear translocation, a reduction in total and activated IRE1α and a decrease in ATF6α pathway activation. Recent analysis of ATF6α-deficient fibroblasts has revealed that ATF6α action is crucial for the UPR-dependent transcription of ER chaperones and that heterodimerization of ATF6α and XBP-1 mediate transcriptional induction of endoplasmic reticulum-associated protein degradation genes 51 . Thus, further studies exploring the interplay between p85α, ATF6α activation and XBP-1 will be crucial in identifying other points of regulatory convergence.
The magnitude of the decrease in XBP-1s in response to decreases in p85α is comparable to or greater than that observed in XBP-1 haploinsufficient mice, suggesting that the UPR perturbations resulting from decreased p85α expression may have a similar underlying mechanism; that is, a decline in XBP-1 expression. XBP-1 heterozygous knockout mice have shown signs of elevated ER stress and have reduced insulin signaling and an associated decrease in whole-body insulin sensitivity when placed on a high-fat diet 19 . However, XBP-1-haploinsufficient mice fed a normal diet show normal plasma insulin, C-peptide and glucose concentrations, suggesting that an additional lesion is required to unmask a metabolic phenotype 19 . By comparison, mice with heterozygous deletion of p85α, homozygous inactivation of p85β or targeted deletion of p85α in liver show enhanced, rather than diminished, insulin sensitivity [52] [53] [54] . These data suggest that, given the blunted nuclear accumulation of XBP-1s in the liver cells of L-Pik3r1 −/− mice upon experimentally induced ER stress, it is likely that XBP-1 and p85α haploinsufficiency regulate insulin sensitivity through multifactorial and at least partially distinct pathways or that obesity may be required to unmask XBP-1-dependent insulin resistance.
Over the past decade, it has become clear that inflammation is a common feature of obesity and type 2 diabetes 40, 55, 56 . In obese mice, there is a ~50% reduction in p85α expression in liver 57 . These mice also show signs of heightened ER stress, including enhanced PERK phosphorylation, increased BiP expression and JNK1 activation 19 . Although there are many factors contributing to the insulin resistance in obesity, these data suggest a model where decreases in p85α lead to a reduced cellular response to ER stress via a reduction in XBP-1 stability, nuclear translocation or both and a concomitant decrease in ATF6α pathway activation.
One might predict that the failure of L-Pik3r1 −/− mice to adequately resolve ER stress could, over long periods of time, lead to an enhanced inflammatory response. In this regard, we have found that, on prolonged follow-up, L-Pik3r1 −/− mice develop progressive inflammatory changes in the liver that culminates in the development of hepatoma (C.Taniguchi, J.N.W., T.Kondo, R.T.Bronson, A.R.Guimaraes et al., unpublished data). UPR dysregulation may underlie the ability of tumors to escape hypoxia-induced apoptosis and may also have a key role in other diseases, including Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis and Alzheimer's disease. Further studies will be needed to determine whether the UPR in these disorders is regulated in a p85-dependent fashion and whether altering p85 expression may be a therapeutic approach to reducing the effects of the UPR in disease pathogenesis. 
METHODS

Methods
ONLINE METHODS
Chemicals and materials. We purchased tunicamycin, protease inhibitor cocktail (4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride, pepstatin A, E-64, bestatin, leupeptin and aprotinin) and streptavidin agarose from Sigma
